Shock, Surgical: Clinical Trials

4 trials for Shock, Surgical, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 41Completed 1

Follow Shock, Surgical: new trials by email Literature Review of Shock, Surgical trials Research Report on Shock, Surgical

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shock and Acute Conditions OutcOmes Platform
Inotrope, Mechanical circulatory support, anti-bodies - Circulatory Shock, Sepsis
UnknownSaint-Louis Hospital, Paris, France10002024-01-012024-04-19
Goal-Directed Fluid Therapy in Patients Undergoing Lower Limb Surgeries
Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index, standard fluid management - Anesthesia, ERAS
Not applicableUnknownZagazig University522023-12-012023-11-15
Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients
Angiotensin II - Shock, Surgical, Shock
Phase 4CompletedUniversity of Illinois at Chicago202020-08-132022-12-21
Thromboelastography in in Patients With Sepsis
Shock, Surgical, Systemic Inflammatory Response Syndrome
UnknownAssaf-Harofeh Medical Center1002009-03-012009-10-14

Narrower conditions

Shock (2)  ·  Edema (1)  ·  Hypotension (1)  ·  Hypovolemia (1)  ·  Sepsis (1)  ·  Shock, Cardiogenic (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Postoperative Complications (4)  ·  Cardiovascular Diseases (2)  ·  Inflammation (2)  ·  Shock (2)  ·  Vascular Diseases (2)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Infections (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Signs and Symptoms (1)

Interventions

Angiotensin II (1)  ·  Vasoconstrictor Agents (1)

Sponsors

Assaf-Harofeh Medical Center (1)  ·  Saint-Louis Hospital, Paris, France (1)  ·  University of Illinois at Chicago (1)  ·  Zagazig University (1)

Countries

Canada (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Alexandre Mebazaa, MD, PhD (1)  ·  Claudia dos Santos, MD, PhD (1)  ·  Mahmoud Abdelkader, MBBCh (1)  ·  Scott T Benken, PharmD (1)

Results publications

PMID 39802301